MLICM
ALKS icon

Metropolitan Life Insurance Company (MetLife)’s Alkermes ALKS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,716
Closed -$236K – 97
2024
Q1 		$236K Sell
8,716
-836
-9% -$23.7K 0.01% 654
2023
Q4 		$265K Hold
9,552
– – 0.01% 615
2023
Q3 		$268K Buy
9,552
+492
+5% +$14.4K 0.01% 576
2023
Q2 		$284K Buy
9,060
+250
+3% +$7.57K 0.01% 557
2023
Q1 		$248K Sell
8,810
-1,471
-14% -$40.1K 0.01% 595
2022
Q4 		$269K Buy
10,281
+453
+5% +$10.8K 0.01% 599
2022
Q3 		$219K Hold
9,828
– – 0.01% 648
2022
Q2 		$293K Hold
9,828
– – 0.01% 580
2022
Q1 		$259K Sell
9,828
-32,309
-77% -$800K 0.01% 705
2021
Q4 		$980K Hold
42,137
– – 0.01% 977
2021
Q3 		$1.3M Sell
42,137
-1,863
-4% -$52.6K 0.02% 781
2021
Q2 		$1.08M Buy
44,000
+40,804
+1,277% +$908K 0.02% 953
2021
Q1 		$59.7K Buy
3,196
+124
+4% +$2.54K ﹤0.01% 2520
2020
Q4 		$61.3K Sell
3,072
-96
-3% -$1.76K ﹤0.01% 2455
2020
Q3 		$52.5K Sell
3,168
-45
-1% -$818 ﹤0.01% 2465
2020
Q2 		$62.3K Sell
3,213
-568
-15% -$9.22K ﹤0.01% 2476
2020
Q1 		$54.5K Hold
3,781
– – ﹤0.01% 2358
2019
Q4 		$77.1K Buy
3,781
+13
+0.3% +$258 ﹤0.01% 2449
2019
Q3 		$73.5K Sell
3,768
-7,569
-67% -$165K ﹤0.01% 2450
2019
Q2 		$256K Sell
11,337
-262
-2% -$7.18K ﹤0.01% 1733
2019
Q1 		$423K Sell
11,599
-242
-2% -$7.99K 0.01% 1412
2018
Q4 		$349K Sell
11,841
-39
-0.3% -$1.44K 0.01% 1448
2018
Q3 		$504K Sell
11,880
-236
-2% -$10.2K 0.01% 1343
2018
Q2 		$499K Buy
12,116
+734
+6% +$33.4K 0.01% 1312
2018
Q1 		$660K Buy
11,382
+3
+0% +$176 0.01% 1102
2017
Q4 		$623K Sell
11,379
-107
-0.9% -$5.46K 0.01% 1135
2017
Q3 		$584K Buy
11,486
+586
+5% +$31.3K ﹤0.01% 1579
2017
Q2 		$632K Buy
10,900
+571
+6% +$33.2K ﹤0.01% 1521
2017
Q1 		$604K Hold
10,329
– – ﹤0.01% 1534
2016
Q4 		$574K Sell
10,329
-465
-4% -$24.9K ﹤0.01% 1650
2016
Q3 		$508K Sell
10,794
-518
-5% -$24.6K ﹤0.01% 1695
2016
Q2 		$489K Buy
+11,312
New +$467K ﹤0.01% 1722
2014
Q3 		– Sell
-9,164
Closed -$467K – 2662
2014
Q2 		$467K Sell
9,164
-146
-2% -$6.73K ﹤0.01% 1873
2014
Q1 		$453K Buy
9,310
+614
+7% +$29.2K ﹤0.01% 1875
2013
Q4 		$354K Hold
8,696
– – ﹤0.01% 2053
2013
Q3 		$292K Sell
8,696
-116
-1% -$3.77K ﹤0.01% 2122
2013
Q2 		$253K Buy
+8,812
New +$257K ﹤0.01% 2173

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ALKS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Alkermes (ALKS) in Q2 2024, closing a stake of 8,716 shares — an estimated $236K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALKS in Q2 2013 and held it in 37 quarters. The position peaked at $1.3M in Q3 2021. 322 funds tracked by Wall St. Rank hold ALKS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Alkermes position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 8,716 Alkermes shares in Q2 2024, an estimated $236K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Alkermes in Q2 2013 and held it in 37 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Alkermes position peaked at $1.3M in Q3 2021.
  • 322 funds tracked by Wall St. Rank held Alkermes as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.